Chemoinformaics analysis of 13-alpha-Hydroxymultiflorine
| Molecular Weight | 262.353 | nRot | 0 |
| Heavy Atom Molecular Weight | 240.177 | nRig | 21 |
| Exact Molecular Weight | 262.168 | nRing | 4 |
| Solubility: LogS | -1.057 | nHRing | 4 |
| Solubility: LogP | 0.533 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 43.5234 |
| nHD | 1 | BPOL | 26.3586 |
| QED | 0.695 |
| Synth | 5.117 |
| Natural Product Likeliness | 2.047 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.998 |
| HIA | 0.085 |
| CACO-2 | -5.069 |
| MDCK | 0.0000269 |
| BBB | 0.385 |
| PPB | 0.170165 |
| VDSS | 1.483 |
| FU | 0.835232 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.067 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.817 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.068 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.537 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.298 |
| CL | 15.036 |
| T12 | 0.713 |
| hERG | 0.024 |
| Ames | 0.15 |
| ROA | 0.024 |
| SkinSen | 0.963 |
| Carcinogencity | 0.932 |
| EI | 0.884 |
| Respiratory | 0.966 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.754697 |